PharmaLinea Podcast

PharmaLinea Podcast
Podcast Description
Stay up to date with the latest trends in the nutraceutical industry. Explore useful expert insights into innovations, emerging ingredients & other key market developments.
Podcast Insights
Content Themes
Explores essential topics in the nutraceutical sector, including doctor-driven influencer marketing, consumer health trends, emerging ingredients, and market evolution with episodes highlighting insights from industry experts like Taeyoon Kim on marketing strategies and Will Cowling on health priority trends.

Stay up to date with the latest trends in the nutraceutical industry. Explore useful expert insights into innovations, emerging ingredients & other key market developments.

We discussed the story of PharmaLinea, the key factors for the company’s success, and how the nutraceutical industry has evolved in these past years with Blaž Gorjup, PharmaLinea’s chairman and founder. Blaž also shared with us the story of his sailing journey (halfway) around the world.
00:00 Introduction
01:11 How it all began
06:09 Why this industry
07:49 From ingredients to finished products
10:47 The beginning of PharmaLinea
12:35 Exhibiting at Vitafoods
13:40 Defining the niche
18:39 Target market analyses and selection
20:52 Key factors for success
29:16 The 5-step programme
30:24 Advice for those just starting out
33:50 Industry evolution
42:44 AI vs. doctors & pharmacists & consumer trust
45:32 Sailing journey
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.